Clinical Trial Update: Effects of Hemoperitoneum Driven Carbon Monoxide on Post-Traumatic Stability and Platelet Aggregation

View source ↗

Summary

A completed clinical trial investigating whether carbon monoxide released in hemoperitoneum affects post-traumatic stability and platelet aggregation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemoperitoneum

Drugs mentioned

• Carbon Monoxide (carbon monoxide)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Hemoperitoneum | Status: COMPLETED